[size=0.688]ORIGINAL ARTICLE
[size=1.5]Share on[size=1.5][url=https://www.nejm.org/#x][size=1.5][/url][size=1.5][url=https://www.nejm.org/#email][size=1.5][/url]
Ianalumab for the Treatment of Patients with Sjögren＊s DiseaseAuthors: Xavier Mariette, M.D., Ph.D. [url=https://orcid.org/0000-0002-4244-5417]https://orcid.org/0000-0002-4244-5417, Thomas Grader-Beck, M.D., Stephanie Finzel, M.D., Elena Schiopu, M.D., Athena Papas, Ph.D., Valerie Devauchelle-Pensec, M.D., Ph.D., Monika Sopala, Ph.D., +24 , for the NEPTUNUS-1 and NEPTUNUS-2 Investigators*Author Info & Affiliations
Published October 21, 2026
N Engl J Med 2026;395:1585-1599
DOI: 10.1056/NEJMoa2601088
|
